Feature Selection Pipelines with Classification for Non-targeted Metabolomics Combining the Neural Network and Genetic Algorithm.
Anna LisitsynaFranco MoritzYouzhong LiuLoubna Al SadatHans HaunerMelina ClaussnitzerPhilippe Schmitt-KopplinSara ForcisiPublished in: Analytical chemistry (2022)
Non-targeted metabolomics via high-resolution mass spectrometry methods, such as direct infusion Fourier transform-ion cyclotron resonance mass spectrometry (DI-FT-ICR MS), produces data sets with thousands of features. By contrast, the number of samples is in general substantially lower. This disparity presents challenges when analyzing non-targeted metabolomics data sets and often requires custom methods to uncover information not always accessible via classical statistical techniques. In this work, we present a pipeline that combines a convolutional neural network with traditional statistical approaches and an adaptation of a genetic algorithm. The developed method was applied to a lifestyle intervention cohort data set, where subjects at risk of type 2 diabetes underwent an oral glucose tolerance test. Feature selection is the final result of the pipeline, achieved through classification of the data set via a neural network, with a precision-recall score of over 0.9 on the test set. The features most relevant for the described classification were then chosen via a genetic algorithm. The output of the developed pipeline encompasses approximately 200 features with high predictive scores, providing a fingerprint of the metabolic changes in the prediabetic class on the data set. Our framework presents a new approach which allows to apply complex modeling based on convolutional neural networks for the analysis of high-resolution mass spectrometric data.
Keyphrases
- deep learning
- neural network
- convolutional neural network
- mass spectrometry
- machine learning
- electronic health record
- big data
- high resolution
- liquid chromatography
- artificial intelligence
- high resolution mass spectrometry
- randomized controlled trial
- genome wide
- cardiovascular disease
- healthcare
- cancer therapy
- escherichia coli
- dna methylation
- metabolic syndrome
- magnetic resonance imaging
- data analysis
- copy number
- staphylococcus aureus
- gas chromatography
- high performance liquid chromatography
- cystic fibrosis
- social media
- gene expression
- candida albicans
- energy transfer